Orforglipron (orforglipron): Complete Guide 2026
Orforglipron is an investigational oral non-peptide GLP-1 receptor agonist being developed by Eli Lilly. Unlike Rybelsus (oral semaglutide), which is a peptide requiring a special absorption enhancer and strict fasting rules, orforglipron is a small molecule that can be taken as a simple daily pill without food restrictions. Phase 2 trials showed approximately 14-15% weight loss, and Phase 3 trials are ongoing. If approved, it could dramatically expand access to GLP-1 therapy by eliminating the need for injections.
Enzo's Tip
A pill that works like an injection? Enzo is amazed — it's like a tiny kibble that packs the punch of a whole can of tuna! Orforglipron isn't available yet, but it could be a game-changer for anyone who doesn't love needles. Enzo is watching this one closely! 💊🐱
Track your Orforglipron journey with Enzo
Dose tracking, side effect logging, and a cute cat cheering you on. Free to download.
Quick Facts
| Generic Name | orforglipron |
| Manufacturer | Eli Lilly |
| Type | Oral tablet |
| Frequency | Once daily |
| Primary Indication | Chronic weight management |
Orforglipron Guides
Enzo reminds you when your next Orforglipron dose is due
Dose tracking, side effect logging, and a cute cat cheering you on. Free to download.
Frequently Asked Questions
The guide your doctor doesn't have time to give you
Your complete Orforglipron playbook: week-by-week guide, what to eat when nothing sounds good, and how to manage every side effect. Free.
No spam. Unsubscribe anytime.
Medical Disclaimer: Enzo is a tracking companion, not a doctor. Always consult your healthcare provider before starting, stopping, or changing any medication. The information on this page is for educational purposes only and should not be considered medical advice. Individual results may vary.